DAG1 and myopathy: The baseline signature was defined from two myopathies in which the dystroglycan complex was disrupted (BMD and LGMDR9) and myopathy in which membrane integrity is the driver of disease (LGMGR12), demonstrating the universal utility of this proteomic signature.